Pregled bibliografske jedinice broj: 399323
Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents
Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents // Scientific evidence of the use of propolis in ehtnomedicine / Oršolić, Nada ; Bašić, Ivan (ur.).
Lahti: Transworld Research Network, 2008. str. 195-222
CROSBI ID: 399323 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Benefits of use of propolis and related flavonoids against the toxicity of chemotherapeutic agents
Autori
Oršolić, Nada ; Horvat Knežević, Anica ; Benković, Vesna ; Bašić, Ivan
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
Scientific evidence of the use of propolis in ehtnomedicine
Urednik/ci
Oršolić, Nada ; Bašić, Ivan
Izdavač
Transworld Research Network
Grad
Lahti
Godina
2008
Raspon stranica
195-222
ISBN
978-81-7895-357-1
Ključne riječi
Propolis, Flavonoids, Chemoterapeutics, Immunomodulation, Genotoxicity
Sažetak
Standard cancer therapies commonly require multiple agents. However, use of multiple agents contributes to increased toxicity resulting in poor treatment outcome. Thus, combined chemotherapy must be optimized to increase tumor response and at the same time lower its toxicity. Antioxidants have been shown to enhance the effect of certain chemotherapeutic agents on tumor cells in vitro and in vivo. However, this effect differs depending upon the type of tumor and the drugs. The objective of this study was to see whether pretreatment with antioxidant mixture could enhance the cytotoxic and apoptotic effect of commonly used chemotherapeutic agents, irinotecan, cisplatin, doxorubicin and epirubicin for the treatment of Echrlich ascites tumor or of mammary carcinoma in mice. Chemotherapeutic agents are known to induce nuclear factor KB (NF- B) activity in tumor cells, resulting in lower cell killing and drug resistance. Collectively, our studies and those by others showed that different polyphenolic/flavonoid components separated from propolis as well as propolis alone could „ sensitize“ cancer cells to chemotherapeutic agents, likely by blocking NF- B activation induced by chemotherapeutic agents both in vitro and in vivo. These results provide experimental evidence showing that novel therapeutic strategies for human cancer could be developed to achieve better treatment outcome by introducing flavonoids in the therapeutic regimen. Positive outcome of combined treatment with propolis and chemotherapeutics was expressed by the influence of these treatments on reduced cytotoxicity to peripheral blood leukocytes, liver and kidney cells.Therefore, polyphenolic/flavonoid components could be potentially useful in combination with chemotherapeutic agents for the treatment of different types of human cancer.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Veterinarska medicina
POVEZANOST RADA
Projekti:
119-0000000-1255 - Kemoprevencija rasta tumora polifenolnim sastavnicama (Oršolić, Nada, MZOS ) ( CroRIS)
119-0532265-1254 - Imunoadjuvantno i zaštitno djelovanje propolisa u životinja (Benković, Vesna, MZOS ) ( CroRIS)
Ustanove:
Prirodoslovno-matematički fakultet, Zagreb
Profili:
Vesna Benković
(autor)
Ivan Bašić
(autor)
Anica Horvat Knežević
(autor)
Nada Oršolić
(autor)